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Abstract
Background: To understand geographic variation in access to care over time in patients with kidney disease.
Methods: We analyzed 4404 (weighted sample of 4,251,129) adults with kidney disease from the United
States using the Medical Expenditure Panel Survey over 10 years. Three dependent variables were created to
investigate variation in access: usual source of care, overall medical access to care, which took into account
usual source of care, ability to get care, and delay in care, and prescription access, which took into account
ability to get prescriptions and delay in getting prescriptions. Multiple logistic regression was used with
geographic region as the main independent variable, adjusting for relevant covariates.
Results: Compared to the Northeast region, adults living in the Midwest (OR = 0.56; 95 % CI 0.35–0.89), South (OR = 0.
48; 95 % CI 0.32–0.72) and West (OR = 0.53; 95 % CI 0.34–0.84) had significantly lower odds of reporting usual source of
care. For the combined access measure, compared to Northeast, adults in Midwest (OR = 0.60; 95 % CI 0.40–0.88),
South (OR = 0.62; 95 % CI 0.44–0.88) and West (OR = 0.50; 95 % CI 0.34–0.72) had significantly lower odds of medical
access to care. Region was not significantly associated with the odds of having prescription access, though a significant
increase in prescription access was observed over time.
Conclusions: Geographic variation in access to care among adults with kidney disease exists independent of income,
education, insurance and comorbid conditions, with those in the South least likely to have a usual source of care and
those in the West least likely to have overall access to care when compared to the Northeast United States.
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Background
A fundamental link between healthcare systems and the
populations they serve is access to care, which is a
multidimensional concept concerned with determining
whether those who need care can enter the healthcare
system [1–3]. The Institute of Medicine defined access
as “a timely use of personal health services to achieve
the best possible health outcomes” [4]. While actual
access can be gauged by health care utilization informa-
tion, measures gathering information on the ability to
receive care when it is needed may be more appropriate
[2, 3]. As a result, global measures of access, such as
having a primary care provider, ability to obtain care
when needed, or delay in needed medical care, help
evaluate overall access to care over time [3].
Studies have identified barriers to care to include
financial, psychological, social, organizational, spatial,
and temporal factors; and differences by social character-
istics and enabling resources may indicate inequitable
care [3, 5]. Investigations note inequity in access for
low-income and minority populations including irregular
source of care, lack of preventative care, and delay in
obtaining needed care [3, 4]. However, fewer studies
investigate regional differences in care. As region is an
immutable personal factor in healthcare, variations in
this measure offer insight on system-level factors that
may need targeted interventions [2]. An analysis using
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data from the Medical Expenditure Panel Survey (MEPS)
found regional differences in care for the general popula-
tion. Americans in the West and South were less likely
to have a usual source of health care than those in the
Northeast and Midwest [1]. It also revealed that those in
the Northeast were the least likely to encounter difficulty
or delay in obtaining medical care [1]. Large regional
variations were also seen in the proportion of Americans
that report having a regular doctor and those diagnosed
with a chronic disease that report visiting their doctors
in the past 2 years [6]. As regional accessibility involves
social dimensions of access beyond constraints due to
distance or travel, it is important to investigate and
better understand differences in access to care [7].
Chronic medical diseases, such as kidney disease, are
particularly important to consider in an analysis of
access to care because those with a usual source of care
are more likely to obtain treatment for chronic health
conditions [1]. However, though those disabled with
end-stage renal disease (ESRD) receive coverage through
Medicare, disparities in outcomes and access to quality
care continue [8]. For instance, socioeconomic and or
geographic variation has been reported in Medicare
spending for people with ESRD and in the kidney trans-
plant population, and racial/ethnic minorities have a
greater burden and worse outcomes for chronic kidney
disease (CKD) [9–13]. Eliminating barriers to care for
those with kidney disease or risk factors for kidney
disease continues to be a concern. Specifically, there is a
need to provide access to care in order to monitor
pre-dialysis care and prevent progression of disease
[8, 14, 15]. Studies have found differences in access
by poverty status, incidence and awareness of disease,
and variation in Medicaid coverage; however, most
studies focus on understanding disparities in kidney trans-
plantation rather than kidney disease [8, 10, 16–18]. As a
result, the association between geographic variation and
access to care over time in patents with kidney disease
remains unclear. To our knowledge, no study has
used national data over a prolonged time period to
examine geographic variation in access among adults
with kidney disease.
Therefore, the aim of this study is to understand geo-
graphic variation in access to care over time in patients
with kidney disease. In an effort to understand changes
over time and inform policy decisions, this analysis uses
global definitions for access, broadens the disease classi-
fication beyond only CKD or ESRD, and uses national
data to allow for generalizable estimates.
Methods
Data source and sample
We analyzed the responses of 4404 adults (≥18 years)
with kidney disease from the United States using the
Medical Expenditure Panel Survey (MEPS) for the years
2002–2011. MEPS is a nationally representative survey
of the U.S. civilian non-institutionalized population and
is administered by the Agency for Healthcare Research
and Quality [19, 20]. MEPS obtains comprehensive
information on participants’ use of medical care, pre-
scription medication and their medical spending, as well
as information on demographics, socioeconomics and
satisfaction with health care. The complex survey design
includes multistage sampling, clustering and stratifica-
tion with oversampling of minorities [21]. Using weights
provided by the Agency for Healthcare Research and
Quality to account for sampling, the weighted sample
for this analysis represented 4,251,129 adults with kidney
disease living in the United States.
Self-reported information is collected from respondents,
in addition to collection of data on medical and financial
variables from all types of health care providers for valid-
ation and supplementation [19]. Diagnosis coded accord-
ing to International Classification of Disease, Ninth
Revision, Clinical Modification (ICD-9-CM) are also
collected. Kidney disease related medical conditions and
procedures reported by respondents were recorded by an
interviewer as verbatim and then converted by profes-
sional coders to ICD-9-CM codes. Fully specified ICD-9-
CM codes were collapsed into three digits in order to
protect confidentiality of respondents [20]. The error rate
for any coder did not exceed 2.5 % on verification [22].
For each year, data were merged from the medical condi-
tion files and the full-year consolidated files using the
unique person identifier (DUPERSID) on a one-to-one
match [20]. To ensure sufficient sample size and robust
estimation for our analysis [23–25], we pooled the 10-year
MEPS data.
Measures
All measures are based on previously validated question-
naires that are publicly available on the MEPS website
[19, 20]. Individuals with kidney disease were identified
from the MEPS household medical condition files using
clinical classification categories (CCCs) codes of 156
(nephritis, nephrosis, renal sclerosis), 157 (acute and
unspecified renal failure), 158 (chronic renal failure),160
(calculus of urinary tract) and 161 (other diseases of
kidney and ureters) [20].
The dependent variables in this study were dichoto-
mized variables created from questions asked in the
access section of MEPS. The first access variable was
Usual Source of Care, as determined by response to the
question: Do you have a usual source of care provider?
An overall Medical Access to Care variable was created
from responses to three separate questions: 1) Do you
have a usual source of care provider?, 2) Were you
unable to get necessary medical care?, and 3) Were you
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delayed in getting necessary medical care?. If respon-
dents answered ‘yes’ to having a usual source of care, ‘no’
to being unable to get necessary care, and ‘no’ to having
a delay in necessary medical care they were coded as
having Medical Access. Opposite answers to any of the
three questions resulted in being coded as not having
Medical Access. An overall Prescription Access to Care
variable was created from responses to two questions: 1)
Were you unable to get necessary prescription medica-
tion?, and 2) Were you delayed in getting necessary
prescription medication? [20]. Similarly to Medical
Access, if respondents answered ‘no’ to being unable to
get prescriptions, and ‘no’ to having a delay in necessary
prescriptions they were coded as having Prescription
Access. Opposite answers to either of the two questions
resulted in being coded as not having Prescription
Access.
The primary independent variable was census region
coded as: Northeast, Midwest, South and West.
Covariates
All covariates used for analysis were based on self-report
and were included to take into account sociodemo-
graphic differences between the regions. Binary indica-
tors of co-morbidities were based on a positive response
to a question “Have you ever been diagnosed with…?”.
Cardiovascular disease (CVD), however, was a positive
response to diagnosis with coronary heart disease, an-
gina, myocardial infarction, or other heart diseases.
Race/ethnic groups are categorized as: Non-Hispanic
White (NHW), Non-Hispanic Black (NHB), Hispanic or
others. Education was categorized as: less than high
school (≤ grade 11), high school (grade 12) and college
or more (grade ≥ 13). Marital status was coded as:
married, non-married (widowed/divorced/separated) and
never married. Gender was dichotomized and age was
coded into three age groups: 18–44, 45–64 and ≥
65 years. Metropolitan Statistical Areas (MSA) was
dichotomized based on population as of end of the year.
Health insurance was coded as: private, public only and
uninsured at all time in the year. The income level was
defined as a percentage of the poverty level and grouped
in to four categories: poor (<125 % of poverty level), low
income (125 % to less than 200 % of poverty level), mid-
dle income (200 % to less than 400 % of poverty level)
and high income (≥400 % of poverty level). Calendar
year was grouped into 2002/03, 2004/05, 2006/07, 2008/
09, 2010/11 for the pooled data.
Statistical analysis
We used multiple logistic regressions with binary vari-
ables of Usual Source of Care, Medical Access to Care,
and Prescription Access to Care as the dependent vari-
ables (yes versus no) across geographic region, adjusting
for age, sex, race/ethnicity, marital status, education, in-
surance status, MSA status, household income, comor-
bidities and calendar year. For interpretation, we use the
adjusted odds ratio coefficient of the logistic regression.
F-adjusted mean residual goodness-of-fit was applied
to test the adequacy of the models. After fitting the lo-
gistic regression models taking the survey design in to
account, the F-adjusted mean residual goodness-of-fit
suggested no evidence of lack of fit [26]. The link test
that account complex survey design, used as a diagnostic
test to examine the model specification error, verified no
evidence of model specification error in the models [27].
Using the Variance inflation factor (VIF) test, and taking
into account the complex survey design, it was deter-
mined that no multicollinearity problems existed between
predictors of the models. All analyses were performed at
the person-level using STATA 14 (StataCorp LP College
Station, TX). Only estimates that are statistically signifi-
cant at the p < 0.05 level are discussed.
Results
Characteristics of U.S. Adults with kidney diseases (KD)
Characteristics of adults with kidney diseases (KD) in
the study are summarized in Table 1. Of the sample
population representing 4404 U.S. adults with KD,
15.5 % were from Northeast, 19.7 % were from Midwest,
42.5 % were from South and the remaining 22.3 % were
from the West region. Non- Hispanic Whites with KD
were more likely in the Midwest region (83.2 compared
to 73.6 % mean), Non-Hispanic Blacks with KD were
more likely in the South region (14.4 compared to
11.3 % mean), and Hispanic and Others with KD were
more likely in the West region (22.9 compared to 11.1 %
mean for Hispanics, and 9.1 compared to 4.0 % mean
for Other) (p < 0.001). Privately insured adults with KD
were least likely in the West (57.4 compared to 64.4 %
mean), whereas publicly insured adults with KD were
more likely in the West (33.3 compared to 28.2 % mean),
and uninsured adults with KD were more likely in the
South and West regions (9.3 for both compared to 7.4 %
mean) (p < 0.001). Poor and low income individuals with
KD were more likely in the Midwest region (22.4 com-
pared to 19.6 % mean), while high income individuals
with KD were more likely in the Northeast region (41.3
compared to 36.3 % mean) (p < 0.001).
Access to care
Table 2 presents the results from the logistic regression
of whether adults with KD indicated usual source of
care. In Table 3, we report our findings from logistic re-
gression of whether adults with KD had medical access
to care, as defined in the methods. Table 4 shows the
logistic regression of whether adults with KD had
prescription access.
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Table 1 Sample demographics by geographical region among U.S. adults with kidney disease (KD)
Variables All (%) Northeast (%) Midwest (%) South (%) West (%) P-value
N (n) 4,251,128 (4404) 797,487 (683) 880,779 (869) 1,746,049 (1870) 826,813 (982)
Age category
Age 18–44 29.6 29.7’ 30.1 29.7 29.0 0.799
Age 45–64 36.6 38.7 37.5 36.0 34.5
Age 65–85 33.8 31.6 32.4 34.3 36.5
Gender
Male 51.2 49.8 52.8 51.2 50.9 0.885
Female 48.8 50.2 47.2 48.8 49.1
Race/ethnicity
Non-Hispanic White 73.6 75.9 83.2 73.0 62.5 <0.001
Non-Hispanic Black 11.3 9.7 11.8 14.4 5.5
Hispanic 11.1 10.6 3.1 9.8 22.9
Other 4.0 3.8 1.9 2.8 9.1
Marital status
Married 56.9 57.4 60.5 55.1 56.5 0.254
Non-married a 28.6 25.0 27.0 30.7 29.5
Never married 14.5 17.6 12.5 14.2 14.0
Education category
< High school 21.9 17.8 20.4 24.2 22.7 0.011
High school 33.1 40.3 35.1 30.3 29.8
College or more 45.0 41.9 44.5 45.5 47.5
Insurance
Private 64.4 68.9 67.5 64.0 57.4 <0.001
Public 28.2 26.1 28.3 26.7 33.3
Uninsured 7.4 5.0 4.2 9.3 9.3
Metropolitan statistical status
MSA 81.3 86.3 73.1 81.1 85.6 0.014
Non-MSA 18.7 13.7 26.9 18.9 14.4
Poverty category
Poor/NEA 19.6 18.5 16.9 20.3 22.4 <0.001
Low Income 15.5 14.1 17.7 15.1 15.2
Middle Income 28.6 26.1 29.6 29.0 28.8
High Income 36.3 41.3 35.8 35.6 33.6
Chronic conditions
Diabetes 28.9 25.6 28.3 29.6 31.5
Hypertension 56.1 52.2 56.2 56.6 59.0 0.347
CVD 30.4 28.3 29.9 30.6 32.3 0.679
Stroke 8.4 7.9 8.3 7.8 10.1 0.642
Emphysema 4.1 3.2 3.2 4.7 4.3 0.457
Joint pain 51.0 44.6 51.9 52.8 52.6 0.022
Arthritis 41.9 39.9 44.1 43.5 38.2 0.162
Asthma 11.5 11.0 10.0 11.9 12.8 0.521
Year category
Year 2002/03 17.7 18.4 18.9 17.6 16.0 0.901
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Compared to the Northeast region, adults living in
the Midwest (OR = 0.56; 95 % CI 0.35–0.89), South
(OR = 0.48; 95 % CI 0.32–0.72) and West (OR = 0.53;
95 % CI 0.34–0.84) had significantly lower odds of
reporting a usual source of care. Other covariates
significantly associated with usual source of care in-
cluded higher age, (aged 45–64 (OR = 2.0; 95 % CI
1.48–2.85) and aged 65–85 (OR = 2.95; 95 % CI 1.96–
4.43), female gender (OR = 1.43; 95 % CI 1.10─1.87).
Covariates significantly associated with less usual source
of care included uninsured (OR = 0.28; 95 % CI 0.20–
0.40). Comorbid conditions like diabetes (OR = 1.47; 95 %
CI 1.02–2.12), hypertension (OR─2.08; 95 % CI 1.53–
2.81) and CVD (OR = 1.56; 95 % CI 1.09–2.21) had a
higher odds but emphysema had a lower odds (OR = 0.37;
95 % CI 0.16–0.86) of having usual source of care. Com-
pared to the bench mark year of 2002/03, calendar year
2008/09 had a lower odds of having a usual source of care
(OR = 0.65; 95 % CI 0.43–0.97).
When considering the combined access measure, com-
pared to Northeast region, adults in Midwest (OR = 0.60;
95 % CI 0.40–0.88), South (OR = 0.62; 95 % CI 0.44–
0.88) and West (OR = 0.50; 95 % CI 0.34–0.72) had
significantly lower odds of medical access to care. Again
more access was associated with age (aged 45–64 (OR =
1.80; 95 % CI.39–2.32) and aged 65–85 (OR–2.70; 95 %
CI 1.91 – 3.82)), and female gender (OR = 1.22; 95 % CI
1.0–1.48). Other race/ethnicity had a lower odds of med-
ical access (OR = 0.55; 95 % CI 0.35–0.85) compared
with their non-Hispanic white counterparts, as did unin-
sured adults (OR = 0.22; 95 % CI 0.16–0.30) compared
with privately insured groups. Higher income groups
had statistically significant higher odds of medical
access (OR = 1.46; 95 % CI 1.05–2.03). Adults with
comorbid hypertension had higher odds of medical
access (OR = 1.52; 95 % CI 1.20–1.93), but joint pain
had a lower odds (OR = 0.75; 95 % CI 0.59–0.94)
compared to their counter parts.
Region was not significantly associated with the odds
of having prescription access, and compared to 2002/03,
both calendar years (2006/07 and 2008/09) were associ-
ated with higher odds of prescription access.
Discussion
The results of this study demonstrate geographic vari-
ation in access to care in patients with kidney disease
over time, with a significant decrease in having a usual
source of care in 2008/09 compared to 2002/03. Access
to prescriptions showed no geographic variation, how-
ever, there was a significant increase in access to pre-
scription medications across the years investigated.
Amongst adults with kidney disease, living in the South,
West, and Midwest is associated with a lower likelihood
of usual source of care and lower overall access to care
compared to living in the Northeast. Additionally, adults
with kidney disease with comorbid diabetes, hyperten-
sion, and CVD had 1.5 to 2 times higher likelihood of
usual source of care whereas those with comorbid em-
physema had a lower likelihood of usual source of care.
To our knowledge, this study is the first of its kind to
investigate trends in geographical variation in access to
care over a decade using a nationally representative
sample among adults with kidney disease. While prior
research has established geographic variation in access
to care among patients with ESRD and kidney trans-
plantation [10, 16, 17], this study demonstrates disparate
access to care for patients with any diagnosis of kidney
disease. This suggests that poor outcomes for those with
CKD and ESRD may be linked to barriers to access
occurring early in the disease process. Lack of regular
access to care may serve to compound disease burden
and result in the early onset of disease related complica-
tions. For instance, as reported by the US Renal Data
System, nearly half of the patients who started receiving
treatment for CKD never received care from a nephrolo-
gist prior to CKD onset [28]. While barriers to care are
multidimensional and can be influenced at the patient
level by disease awareness and patient preference; the
geographic variation in access, as well as outcomes, sug-
gest that system level barriers to access may have an
Table 1 Sample demographics by geographical region among U.S. adults with kidney disease (KD) (Continued)
Year 2004/05 18.4 17.3 19.6 18.5 17.8
Year 2006/07 19.3 20.9 19.1 18.6 19.5
Year 2008/09 20.9 22.2 20.6 20.0 22.0
Year 2010/11 23.7 21.2 21.8 25.3 24.7
Access
Usual source of care 89.7 93.4 90.6 88.1 88.8 0.004
Medical access 82.1 88.1 82.6 81.2 77.9 <0.001
Prescription access 91.8 94.4 92.2 90.8 90.8 0.064
N-weighted sample size; n-unweighted sample size; %, weighted percentage
aNon-married stands for widowed/divorced and separated
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impact on disease complications and outcomes through
a patient’s ability to obtain care.
In this analysis we investigated three related, but con-
ceptually separate measures of access to care: having a
usual source of care, a more comprehensive measure of
access incorporating considerations including delay of
care, and having access to prescriptions. As access is a
complex construct, it is important to consider all three
to have a better understanding of overall access to care
for patients with kidney disease. These results suggest
that while there are no geographic differences in access
to prescriptions, differences do exist in access to medical
care, whether using a more basic measure such as usual
source of care, or a more comprehensive measure. In
addition, while in both medical access measures, those
with kidney disease in the Northeast were more likely to
have access, the relative differences between other re-
gions and the Northeast differed between the two mea-
sures. While those in the South had the lowest odds of
having a usual source of care, it was those in the West
that had the lowest odd of having access when taking
ability to obtain care, and not having a delay in care into
account. These results support findings of a common-
wealth fund report that revealed geography influences
access to care and quality of care [29]. Similar to our
study, they found that areas in the Northeast and Midwest
had higher measures of access compared to areas in the
South. They also found strong relationships between ac-
cess to care and outcomes, with better access being associ-
ated with better outcomes. In the Southeast region, it has
also been reported that testing and detection effort are
low compared to other regions [30]. Unfortunately, this
at-risk region (the Southeast) has the highest prevalence
of recognized CKD, further suggesting the need to exam-
ine the impact that system level barriers may have in the
variation in access for patients with kidney disease and
those at risk for CKD and ESRD.
Table 2 Logistic regression model for usual source of care
among adults with kidney disease (KD) by geographical status
Variables Odds ratio 95 % CI p value
Primary independent variables
Northeast (ref) – – –
Midwest 0.56* 0.35–0.89 0.016
South 0.48** 0.32–0.72 0.001
West 0.53** 0.34–0.84 0.007
Covariates
Age
Age 18–44 (ref) – – –
Age 45–64 2.0*** 1.48–2.85 <0.001
Age 65–85 2.95*** 1.96–4.43 <0.001
Gender
Female 1.43** 1.10–1.87 0.008
Race/ethnicity
Non-Hispanic White (ref) – – –
Non-Hispanic Black 0.92 0.58–1.48 0.753
Hispanic 0.71 0.49–1.02 0.071
Others 0.65 0.38–1.11 0.119
Marital Status
Married (ref) – – –
Not married a 0.64* 0.45–0.93 0.019
Never married 0.61** 0.44.–0.84 0.003
Education
< High school (ref) – – –
High school 0.86 0.60–1.22 0.403
College or more 0.82 0.58–1.15 0.262
Insurance Status
Private (ref) – – –
Public insured 1.02 0.70–1.49 0.909
Uninsured 0.28*** 0.20–0.40 <0.001
MSA status
MSA 1.10 0.79–1.55 0.544
Poverty Category
Poor/NEA (ref) – – –
Low Income 1.13 0.74–1.72 0.543
Middle Income 1.33 0.93–1.92 0.115
High Income 1.44 0.94–2.18 0.086
Chronic Conditions b
Diabetes 1.47* 1.02–2.12 0.034
Hypertension 2.08*** 1.53–2.81 <0.001
CVD 1.56** 1.09–2.21 0.014
Stroke 1.05 0.49–2.23 0.896
Emphysema 0.37* 0.16–0.86 0.022
Joint Pain 1.12 0.83–1.51 0.444
Table 2 Logistic regression model for usual source of care
among adults with kidney disease (KD) by geographical status
(Continued)
Arthritis 1.38 0.97–1.97 0.071
Asthma 1.35 0.89–2.05 0.148
Year
Year 2002/03 (ref) – – –
Year 2004/05 0.93 0.62–1.41 0.766
Year 2006/07 0.72 0.48–1.08 0.117
Year 2008/09 0.65* 0.43–0.97 0.039
Year 2010/11 0.80 0.52–1.22 0.306
*Level of significance p < 0.05; **level of significance p < 0.01, ***level of
significance p < 0.001
aNon-married stands for widowed/divorced and separated
bReference for each chronic conditions was not having that specific condition
Ozieh et al. BMC Health Services Research  (2016) 16:585 Page 6 of 9
The Healthy People 2020 objective for chronic kidney
disease (CKD) is to reduce new cases of CKD and its
complications, disability, death and economic costs [31].
Access to care ensures at-risk individuals get timely, pre-
ventative and recommended care so as to obviate when
possible the complications and economic burden of
kidney disease. Lack of access to care not only affects an
individual’s ability to maintain their health, but also
negatively impacts quality of life as a whole. Therefore,
understanding geographic variation in access is vital for
establishing successful policies geared towards reducing
the incidence, prevalence and complications of kidney
disease across the nation [30]. The Affordable Care Act
(ACA) is one of the most recent national undertakings
to improve access to care. The ACA—Medicaid expan-
sion was implemented as part of this act to improve
access for low income Americans, but this mandate is
dependent on state implementation [32]. Unfortunately,
many of the states that have chosen not to implement
this law are in at-risk regions of the USA based on this
analysis, such as the Southeast [33]. This study serves as
baseline information for policymakers on existing re-
gional variation in access to care among adults with
kidney disease in the midst of the Affordable Care Act
(ACA) reform. Future studies should consider how the
ACA-Medicaid expansion influenced variations seen.
Conclusions
The strengths of this study include the use of nationally
representative data over a prolonged period, including
broad care categories (access to usual source of care,
medical access care, and prescription access care) and
the use of a robust estimation method to examine geo-
graphic variation in access to care accounting for comor-
bidities among patents with kidney disease. However,
limitations do exist. First, MEPS relies on self-report,
and as such may be prone to potential bias and recall
Table 3 Logistic regression model for medical access to care
among adults with kidney disease (KD) by geographical status
Variables Odds ratio 95 % CI p value
Primary independent variables
Northeast (ref) – – –
Midwest 0.60** 0.40–0.88 0.009
South 0.62** 0.44–0.88 0.008
West 0.50*** 0.34–0.72 <0.001
Covariates
Age
Age 18–44 (ref) – – –
Age 45–64 1.80*** 1.39–2.32 <0.001
Age 65–85 2.70*** 1.91–3.82 <0.001
Gender
Female 1.22* 1.0–1.48 0.048
Race/ethnicity
Non-Hispanic White (ref) – – –
Non-Hispanic Black 1.10 0.78–1.54 0.578
Hispanic 0.99 0.72–1.36 0.975
Others 0.55** 0.35–0.85 0.009
Marital Status
Married (ref) – – –
Not married a 0.65** 0.50–0.85 0.002
Never married 0.62** 0.47–0.83 0.001
Education
< High school (ref) – – –
High school 0.95 0.72–1.26 0.769
College or more 0.91 0.68–1.21 0.542
Insurance Status
Private (ref) – – –
Public insured 1.04 0.79–1.37 0.754
Uninsured 0.22*** 0.16–0.30 <0.001
MSA status
MSA 1.0 0.76–1.33 0.945
Poverty Category
Poor/NEA (ref) – – –
Low Income 1.11 0.78–1.56 0.547
Middle Income 1.25 0.93–1.68 0.124
High Income 1.46* 1.05–2.03 0.024
Chronic Conditions b
Diabetes 1.0 0.74–1.34 0.749
Hypertension 1.52*** 1.20–1.93 <0.001
CVD 1.08 0.85–1.38 0.510
Stroke 0.88 0.59–0.94 0.437
Emphysema 0.70 0.39–1.26 0.241
Joint Pain 0.75* 0.59–0.94 0.014
Table 3 Logistic regression model for medical access to care
among adults with kidney disease (KD) by geographical status
(Continued)
Arthritis 1.19 0.92–1.54 0.166
Asthma 0.92 0.67–1.26 0.626
Year
Year 2002/03 (ref) – – –
Year 2004/05 0.99 0.70–1.40 0.975
Year 2006/07 0.93 0.66–1.32 0.715
Year 2008/09 0.95 0.68–1.31 0.770
Year 2010/11 0.88 0.63–1.24 0.491
*Level of significance p < 0.05; **level of significance p < 0.01, ***level of
significance p < 0.001
aNon-married stands for widowed/divorced and separated
bReference for each chronic conditions was not having that specific condition
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error. However, it is one of the few national dataset with
extensive information on health care access, utilization
and cost, and questions have been validated over time to
collect reliable information. Second, there is no labora-
tory information in MEPS and the ICD-9 codes for
chronic kidney disease are collapsed for confidentiality
reasons, so we are unable to examine geographic trends
by CKD stage. Third, while the panel design of this study
and the ability to investigate responses over different
years provides trends over time, individual respondents
were not followed over time, and therefore the results of
our study should not be interpreted longitudinally.
This study provides insight into geographic variation
in access to care among adults with kidney disease inde-
pendent of income, education, insurance and comorbid
conditions. Compared to the Northeast, living in the
South, West, and Midwest is associated with lower likeli-
hood of having a usual source of care or having overall
access to care. Conversely, no geographic variation was
seen in access to prescription medications. These find-
ings are the first of its kind to examine trends in access
in adults with kidney disease and serves as baseline for
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Availability of data and materials
The datasets generated and analyzed during the current study are available in
the Agency for Healthcare Research and Quality (AHRQc). Medical Expenditure
Panel Survey. 2011 Full year consolidated data file 2013c, Available from http://
meps.ahrq.gov/mepsweb/data_stats/download_data_files.jsp.
Table 4 Logistic regression for prescription access among
adults with kidney disease (KD) by geographical status
Variables Odds ratio 95 % CI p value
Primary independent variables
Northeast (ref) – – –
Midwest 0.77 0.47–1.24 0.284
South 0.68 0.46–1.0 0.051
West 0.64 0.40–1.02 0.064
Covariates
Age
Age 18–44 (ref) – – –
Age 45–64 1.21 0.83–1.76 0.310
Age 65–85 2.6*** 1.65–4.06 <0.001
Gender
Female 0.85 0.64–1.13 0.278
Race/ethnicity
Non-Hispanic White (ref) – – –
Non-Hispanic Black 1.13 0.80–1.61 0.463
Hispanic 1.5* 1.0–2.18 0.049
Others 0.97 0.51–1.82 0.934
Marital Status
Married (ref) – – –
Not married a 0.57** 0.39–0.82 0.003
Never married 0.84 0.54–1.29 0.436
Education
< High school (ref) – – –
High school 1.26 0.87–1.81 0.209
College or more 1.43 0.98–2.09 0.059
Insurance Status
Private (ref) – – –
Public insured 0.77 0.53–1.11 0.164
Uninsured 0.36*** 0.23–0.56 <0.001
MSA status
MSA 0.95 0.66–1.36 0.807
Poverty Category
Poor/NEA (ref) – – –
Low Income 1.14 0.75–1.72 0.519
Middle Income 1.14 0.77–1.70 0.500
High Income 1.22 0.75–1.96 0.408
Chronic Conditions b
Diabetes 0.67* 0.50–0.91 0.011
Hypertension 0.72 0.51–1.0 0.051
CVD 0.80 0.57–1.13 0.214
Stroke 1.06 0.70–1.61 0.763
Emphysema 0.88 0.47–1.65 0.705
Joint Pain 0.55*** 0.39–0.76 <0.001
Table 4 Logistic regression for prescription access among
adults with kidney disease (KD) by geographical status
(Continued)
Arthritis 1.05 0.75–1.45 0.759
Asthma 0.51** 0.35–0.75 0.001
Year
Year 2002/03 (ref) – – –
Year 2004/05 1.30 0.87–1.94 0.193
Year 2006/07 1.65* 1.08–2.52 0.019
Year 2008/09 2.02** 1.32–3.10 0.001
Year 2010/11 1.50 0.96–2.35 0.074
*Level of significance p < 0.05; **level of significance p < 0.01, ***level of
significance p < 0.001
aNon-married stands for widowed/divorced and separated
bReference for each chronic conditions was not having that specific condition
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